<?xml version="1.0" encoding="UTF-8"?>
<ref id="B48">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kibuuka</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Kimutai</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Maboko</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Sawe</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Schunk</surname>
    <given-names>M. S.</given-names>
   </name>
   <name>
    <surname>Kroidl</surname>
    <given-names>A.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2010</year>). 
  <article-title>A Phase I/II study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus-type 5 boost vaccine in HIV uninfected East Africans (RV 172)</article-title>. 
  <source>J. Infect. Dis.</source>
  <volume>201</volume>, 
  <fpage>600</fpage>â€“
  <lpage>607</lpage>. 
  <pub-id pub-id-type="doi">10.1086/650299</pub-id>
  <pub-id pub-id-type="pmid">20078213</pub-id>
 </mixed-citation>
</ref>
